Skip to main content

U S Physical Therapy Inc

USPH
Exchange
NYSE
Industry
Services-Health Services
SEC CIK
0000885978

In the last 90 days, U S Physical Therapy Inc insiders filed 1 open-market purchase and 1 sale; 235 institutions reported holding it in 13F filings for Q3 2026, worth $1.46B in total; no superinvestor holds it.

Currency
USD
Source
SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
Updated
Nov 8, 2026, 10:34 PM ET

Income statement

Each column is one fiscal year, newest first.

Income statement of U S Physical Therapy Inc, annual
Line itemFY2025FY2024FY2023FY2022FY2021
Period endDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Filing10-K10-K10-K10-K10-K
Reported––Feb 28, 2024Feb 23, 2023Feb 24, 2022
Revenue$781.0M$671.3M$604.8M$553.1M$495.0M
Gross profit$149.7M$123.9M$121.5M$112.0M$117.2M
Selling, general and administrative$69.3M$58.3M$52.0M$46.1M$46.5M
Operating income$86.7M$63.2M$52.1M$56.8M$70.6M
Income tax$19.8M$14.6M$12.2M$12.2M$15.3M
Net income$39.6M$31.4M$28.2M$32.2M$40.8M
EPS, basic$1.42$1.84$1.28$2.25$2.41
EPS, diluted$1.42$1.84$1.28$2.25$2.41
Weighted shares, basic15.2M15.1M14.2M13.0M12.9M
Weighted shares, diluted15.2M15.1M14.2M13.0M12.9M
Margins and growth
Gross margin19.2%18.5%20.1%20.3%23.7%
Operating margin11.1%9.4%8.6%10.3%14.3%
Net margin5.1%4.7%4.7%5.8%8.2%
Revenue growth, year over year+16.3%+11.0%+9.3%+11.7%+17.0%
Net income growth, year over year+26.0%+11.3%−12.2%−21.2%+16.0%

Balance sheet

Each column is one fiscal year, newest first.

Balance sheet of U S Physical Therapy Inc, annual
Line itemFY2025!FY2024!FY2023!FY2022!FY2021!
Period endDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Filing10-K10-K10-K10-K10-K
Reported––Feb 28, 2024Feb 23, 2023Feb 24, 2022
Cash and equivalents$35.6M$41.4M$152.8M$31.6M$28.6M
Accounts receivable$64.2M$59.0M$51.9M$51.9M$46.3M
Total current assets$140.0M$137.6M$233.4M$111.3M$95.2M
Property, plant and equipment$35.7M$32.1M$26.1M$24.7M$23.0M
Goodwill$692.4M$667.2M$509.6M$494.1M$434.7M
Intangible assets$172.9M$179.3M$109.7M$108.8M$86.4M
Total assets$1.20B$1.17B$997.2M$858.2M$749.4M
Short-term debt$9.87M$11.0M$7.69M$7.86M$830.0K
Total current liabilities$139.0M$116.3M$102.2M$85.5M$83.5M
Long-term debt$152.6M$142.5M$139.0M$175.8M$117.6M
Total liabilities$433.8M$408.4M$345.0M$373.6M$297.0M
Shareholders' equity$476.9M$490.0M$477.4M$317.1M$297.2M

Cash flow statement

Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.

Cash flow statement of U S Physical Therapy Inc, annual
Line itemFY2025FY2024FY2023FY2022FY2021
Period endDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021
Filing10-K10-K10-K10-K10-K
Reported––Feb 28, 2024Feb 23, 2023Feb 24, 2022
Operating cash flow$75.1M$74.9M$82.0M$58.5M$76.4M
Capital expenditures$14.1M$9.19M$9.29M$8.25M$8.20M
Free cash flow$61.0M$65.8M$72.7M$50.3M$68.2M
Depreciation and amortization$22.4M$18.7M$15.7M$14.7M$11.6M
Stock-based compensation$8.27M$7.82M$7.24M$7.26M$7.87M
Dividends paid$27.4M$26.5M$24.1M$21.3M$18.8M
Share buybacks$5.57M––––
Investing cash flow-$36.7M-$149.4M-$45.0M-$81.3M-$124.1M
Financing cash flow-$44.1M-$37.0M$84.3M$25.8M$43.4M
Net change in cash-$5.79M-$111.5M$121.2M$3.03M-$4.35M
Ratio
Stock-based compensation, % of revenue1.1%1.2%1.2%1.3%1.6%

Shares outstanding

Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.

Shares outstanding for U S Physical Therapy Inc by cover date
Cover dateShares outstandingChange in a yearFiling
Nov 5, 202614.9M−1.8%SEC
Aug 7, 202614.9M−1.9%SEC
May 8, 202615.2M+0.2%SEC
Feb 23, 202615.1M−0.5%SEC
Nov 7, 202515.2M+0.7%SEC
Aug 8, 202515.2M+0.8%SEC
May 9, 202515.2M+0.8%SEC
Mar 3, 202515.2M+0.8%SEC

Notes and known gaps

How these numbers are put together, and what they can't tell you.

  • Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
  • Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
  • A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.

Known gaps

  • Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
  • EPS and share counts are as reported at the time, not adjusted for later stock splits.
  • For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
  • For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
  • Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
  • Depreciation and amortization is missing for some companies that report it under their own XBRL tags.